Founded in 1999, Dexcom, Inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1999
Size (employees)
1,900 (est)+57%
Website
dexcom.com
Dexcom was founded in 1999 and is headquartered in San Diego, US

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr

Dexcom Metrics

Dexcom Financial Metrics

Revenue (2016)

$573.3 m

Revenue growth (2015-16), %

43%

Gross profit

$378.4 m

Gross profit margin (2016), %

66%

Net income (2016)

($65.6 m)

Market capitalization (21-Mar-2017)

$6.7 b

Closing share price (21-Mar-2017)

$79.6

Cash (31-Dec-2016)

$94.5 m
Dexcom's current market capitalization is $6.7 b.
Dexcom's revenue was reported to be $573.3 m in FY, 2016 which is a 42.6% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$160 m$259.2 m$402 m$573.3 m

Revenue growth, %

62%55%43%

Cost of goods sold

$59.9 m$82.9 m$123.6 m$194.9 m

Gross profit

$100.1 m$176.3 m$278.4 m$378.4 m

Gross profit Margin, %

63%68%69%66%

Operating expense total

$129 m$197.8 m$335.5 m$442.3 m

EBIT

($28.9 m)($21.5 m)($57.1 m)($63.9 m)

EBIT margin, %

(18%)(8%)(14%)(11%)

Interest expense

$900 k$800 k$400 k$700 k

Interest income

$400 k

Pre tax profit

($29.8 m)($22.3 m)($57.5 m)($64.9 m)

Income tax expense

($100 k)($700 k)

Net Income

($29.8 m)($22.4 m)($57.6 m)($65.6 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$43.2 m$71.8 m$86.1 m$94.5 m

Accounts Receivable

$26.1 m$42.4 m$74.1 m$101.7 m

Inventories

$9 m$16 m$35.2 m$45.4 m

Current Assets

$93.1 m$145.9 m$231.3 m$280 m

PP&E

$20.7 m$31.2 m$54.7 m$109.4 m

Goodwill

$3.2 m$3.2 m$3.7 m$11.3 m

Total Assets

$122.5 m$184.6 m$292 m$402.8 m

Accounts Payable

Current Liabilities

$32.1 m$40.6 m$66.9 m$102.4 m

Additional Paid-in Capital

$559.5 m$638 m$776.8 m$905.7 m

Retained Earnings

($475.4 m)($497.8 m)($555.4 m)($621 m)

Total Equity

$84.1 m$140.2 m$221.2 m$283.8 m

Financial Leverage

1.5 x1.3 x1.3 x1.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($29.8 m)($22.4 m)($57.6 m)($65.6 m)

Depreciation and Amortization

$7 m$8.4 m$10.8 m$15 m

Accounts Receivable

($6.5 m)($16 m)($32 m)($27 m)

Inventories

($1.6 m)($7 m)($19 m)($9.8 m)

Accounts Payable

Cash From Operating Activities

$2.4 m$23.6 m$49 m$56.2 m

Purchases of PP&E

($7.9 m)($16.2 m)($33.3 m)($55.7 m)

Cash From Investing Activities

$20.9 m($16.8 m)($51.5 m)($55.9 m)

Long-term Borrowings

($200 k)($2.2 m)($2.3 m)($2.3 m)

Interest Paid

$500 k$400 k$300 k$100 k

Income Taxes Paid

$100 k

Dexcom Market Value History

Dexcom Median Salaries

Source: 23 public H-1B filings from Dexcom

Dexcom Online Presence

Dexcom News

Dexcom Company Life

You may also be interested in